NPPA issued a notification regarding fixation of retail price of Glimepiride IP 1mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg

Jun 26, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 24, 2024, issued a notification regarding the fixation of the retail price of Glimepiride IP 1mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg.

The following has been stated: -

•For each Film-coated tablet contains:  Glimepiride IP 1mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg for M/s Mascot Health Series Pvt Ltd (Manufacturer) & M/s Alembic Pharmaceuticals Ltd (Marketer) the retail price is 13.54.

The detailed notification is given in the document attached below.

[Notification No. 19(4013)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT